Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crown Castle International Corp (CCI) vs Tempus AI (TEM) Price & Performance

Crown Castle International CorpTrade

Price performance (Past 24H)

Key statistics

Crown Castle International Corp vs Tempus AI — how do they compare? Crown Castle International Corp trades at $73.66 (market cap $31.32B), while Tempus AI trades at $55.28 (market cap $9.93B). The key difference: Crown Castle International Corp is far larger — about 3.2× Tempus AI's market cap, and Crown Castle International Corp pays a 5.77% dividend while Tempus AI pays none. Which is the better fit depends on your goals.

CCITEM
Market Cap
$31.32B$9.93B
Sector
Real EstateBroad Market / Factor
52-Week High
$103.79$103.25
52-Week Low
$73.61$41.55
Enterprise Value
$53.68B$10.56B
Dividend Yield
5.77%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Crown Castle International Corp

Crown Castle (CCI) trades at $75.59, up 0.89% on the day, but technical indicators signal a bearish trend with the stock near recent lows. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, while revenue has declined from $7.0B in 2023 to $4.26B in 2025. Analyst consensus is split evenly between Buy and Hold with a $95.29 price target, suggesting potential upside. Recent news highlights strategic shifts, including the sale of its fiber business and a focus on U.S. tower operations.

The outlook for CCI hinges on execution of its pure-play tower strategy amid high debt levels and competitive pressures. Investment appeal lies in its 5.5% dividend yield and discounted valuation, but risks include declining revenue, negative shareholder equity, and sensitivity to interest rates. Wall Street sees value if operational improvements materialize.

Tempus AI

Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.

Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.

Returns comparison

Trailing returns across standard periods

About Crown Castle International Corp

Crown Castle International owns and leases roughly 40,000 cell towers in the United States. It also owns more than 85,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company's fiber is primarily leased by wireless service providers to set up small-cell network infrastructure and by enterprises for their internal connection needs. Crown Castle's towers and fiber are predominantly located in the largest U.S. cities. The company has a very concentrated customer base, with more than 70% of its revenue coming from the big three U.S. mobile carriers. Crown Castle operates as a real estate investment trust.

Read more on CCI

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM